VERDE BIO HOLDINGS, INC.: 10-Q filed 2020-04-29
What VERDE BIO HOLDINGS, INC. reported in its quarterly report filed 2020-04-29 (fiscal Q2 2020): 18 published measures, 60 facts as tagged in accession 0001445866-20-000479.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-04-29
- Fiscal period
- fiscal Q2 2020
- Accession
- 0001445866-20-000479 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VERDE BIO HOLDINGS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 38,904 | USD | |
| At 2019-04-30 | 23,752 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 2,379,323 | USD | |
| At 2019-04-30 | 2,030,459 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | -2,340,419 | USD | |
| At 2019-07-31 | -2,236,756 | USD | |
| At 2019-04-30 | -2,006,707 | USD | |
| At 2018-10-31 | -1,266,080 | USD | |
| At 2018-07-31 | -1,143,723 | USD | |
| At 2018-04-30 | -1,524,336 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | -40,478 | USD | 184 |
| 2018-05-01 to 2018-10-31 | -5,656 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | 55,630 | USD | 184 |
| 2018-05-01 to 2018-10-31 | 0 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | -6,593,462 | USD | |
| At 2019-04-30 | -5,946,338 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 1,504,228 | shares | 92 |
| 2019-05-01 to 2019-10-31 | 1,293,341 | shares | 184 |
| 2018-08-01 to 2018-10-31 | 1,268,387 | shares | 92 |
| 2018-05-01 to 2018-10-31 | 962,916 | shares | 184 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 1,504,228 | shares | 92 |
| 2019-05-01 to 2019-10-31 | 1,293,341 | shares | 184 |
| 2018-08-01 to 2018-10-31 | 1,268,387 | shares | 92 |
| 2018-05-01 to 2018-10-31 | 807,528,966 | shares | 184 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -0.17 | USD/shares | 92 |
| 2019-05-01 to 2019-10-31 | -0.5 | USD/shares | 184 |
| 2018-08-01 to 2018-10-31 | -0.1 | USD/shares | 92 |
| 2018-05-01 to 2018-10-31 | 0.21 | USD/shares | 184 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -0.17 | USD/shares | 92 |
| 2019-05-01 to 2019-10-31 | -0.5 | USD/shares | 184 |
| 2018-08-01 to 2018-10-31 | -0.1 | USD/shares | 92 |
| 2018-05-01 to 2018-10-31 | 0 | USD/shares | 184 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -35,302 | USD | 92 |
| 2019-05-01 to 2019-10-31 | -79,059 | USD | 184 |
| 2018-08-01 to 2018-10-31 | -6,865 | USD | 92 |
| 2018-05-01 to 2018-10-31 | -27,091 | USD | 184 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 30,985 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 56,348 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 111,191 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 176,292 | USD | 184 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 35,302 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 79,059 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 6,865 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 27,091 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,660,708 | shares | |
| At 2019-04-30 | 1,074,255 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 4,250,882 | USD | |
| At 2019-04-30 | 3,938,057 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -260,696 | USD | 92 |
| 2019-05-01 to 2019-10-31 | -647,124 | USD | 184 |
| 2018-08-01 to 2018-10-31 | -122,357 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 203,540 | USD | 184 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 5,539 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 7,756 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 5,037 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 13,421 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -225,394 | USD | 92 |
| 2019-05-01 to 2019-10-31 | -568,065 | USD | 184 |
| 2018-08-01 to 2018-10-31 | -115,492 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 230,631 | USD | 184 |
Inspect the source
- Entity
- VERDE BIO HOLDINGS, INC. / CIK 0001490054
- Captured
- 2026-09-19T11:18:19.126Z
- SEC response SHA-256
dd7cd08239c5c2462afbc7dbecad94ca6a89142a02ded38321628f853eea98c8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001490054.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))